(firstQuint)Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF).

 Secondary Objective(s): 1.

 Describe persistence of ALT (alanine aminotransferase) normalization and/or improvement of ALT levels with TAF as with previous anti-HBV treatment 2.

 To describe trends in serum creatinine and calculated creatinine clearance as available by local labs.

 3.

 To describe trends in bone mass from baseline to 24 months after switch.

.

 Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)@highlight

Primary Objective: To describe rate of persistence and/or improvement of viral suppression with TAF as with previous anti-HBV (hepatitis B virus) treatment